NCT03753893View on ClinicalTrials.gov

Ocular Manifestations in Rheumatic Diseases

CompletedOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

May 1, 2013

Primary Completion Date

April 1, 2021

Study Completion Date

November 1, 2021

Conditions
UveitisConjunctivitisKeratoconjunctivitis SiccaXerophthalmiaEye HemorrhageOptic NeuritisPapilledemaOrbital DiseasesRetinal Vein OcclusionRetinal Artery OcclusionMacular EdemaRetinitisChorioretinitisIridocyclitisScleritisChoroid HemorrhageBlindnessAmaurosis Fugax
Interventions
OTHER

No intervention used

no intervention used

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT03753893 - Ocular Manifestations in Rheumatic Diseases | Biotech Hunter | Biotech Hunter